Literature DB >> 2124531

Spontaneous and in vitro activation of synovial fluid and peripheral blood lymphocytes in rheumatoid arthritis.

Y T Konttinen1, T Pettersson, P Kemppinen, C Friman.   

Abstract

Peripheral blood (PB) and synovial fluid (SF) were compared in parallel samples in rheumatoid arthritis (RA). The kinetics of in vitro T-cell activation was assessed in phytohemagglutinin (PHA) stimulated PB or SF mononuclear cell cultures on days 0, 1, 3 and 5. The early lymphocyte activation as assessed by interleukin-2 receptor expression was faster in SF than in PB cell cultures. In particular, IFN-gamma secretion was higher in SF than in PB cell cultures (p less than 0.01). Accordingly, lymphocyte major histocompatibility complex (MHC) locus II antigen expression was higher in SF than in PB cell cultures (53 +/- 7% vs. 21 +/- 5%; p less than 0.01). Our results suggest that lymphocytes, which are particularly effective producers of IFN-gamma when stimulated in vitro are sequestered in the diseased joints in RA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124531     DOI: 10.1007/bf02114392

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma.

Authors:  E M Lemmel; M Franke; W Gaus; P W Hartl; P H Hofschneider; K Miehlke; K Machalke; H J Obert
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

2.  Regulation of histocompatibility antigens by interferon.

Authors:  F Rosa; D Hatat; A Abadie; M Fellous
Journal:  Ann Inst Pasteur Immunol (1985)       Date:  1985 Jan-Feb

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.

Authors:  M Lotz; C D Tsoukas; S Fong; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

5.  Expression of activation markers on CD4+ and CD8+ cells from synovial fluid, synovial tissue, and peripheral blood of patients with inflammatory arthritides.

Authors:  J Hovdenes; G Gaudernack; T K Kvien; T Egeland
Journal:  Scand J Immunol       Date:  1989-06       Impact factor: 3.487

6.  Expression of MHC class II antigen, interleukin-2 receptor, transferrin receptor and gp 40/80 glycoprotein during different phases of a normal PHA-driven lymphocyte activation in vitro.

Authors:  Y T Konttinen; V Bergroth; D Nordström; M Segerberg-Konttinen; E Tolvanen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1986-10

7.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

8.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

9.  Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo.

Authors:  E M Veys; H Mielants; G Verbruggen; J P Grosclaude; W Meyer; A Galazka; J Schindler
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

10.  Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens.

Authors:  G Groenewegen; M de Ley; G M Jeunhomme; W A Buurman
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  1 in total

1.  Frequency of Th17 CD4+ T cells in early rheumatoid arthritis: a marker of anti-CCP seropositivity.

Authors:  Irene Arroyo-Villa; María-Belén Bautista-Caro; Alejandro Balsa; Pilar Aguado-Acín; Laura Nuño; María-Gema Bonilla-Hernán; Amaya Puig-Kröger; Emilio Martín-Mola; María-Eugenia Miranda-Carús
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.